Cambridge Heart, Inc.

Cambridge Heart, Inc. engages in the research, development, and commercialization of products for the non-invasive diagnosis of cardiac disease. It provides Microvolt T-Wave Alternans (MTWA) Module that is designed to work with existing cardiac stress test platforms distributed by other manufacturers as an add-on module; HearTwave II System, which is used to perform MTWA testing and standard cardiac stress testing; Micro-V Alternans Sensors that are multi-segment electrodes used to obtain results from the MTWA Test; and CH2000, a cardiac diagnostic system designed to support a range of standard and physician-customized protocols for conducting and measuring cardiac exercise stress testing. The company sells its products to cardiology group practices, hospitals, and research institutions. It markets its products internationally through independent distributors. The company was incorporated in 1990 and is based in Tewksbury, Massachusetts.